Schering-Plough Acquires Rights to Antibodies
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 27 (Table of Contents)
Published: 2 Aug-2002
DOI: 10.3833/pdr.v2002.i27.1019 ISSN: 1756-7874
Section: Licensing
Abstract
Schering-Plough entered into an agreement to acquire exclusive rights to develop and commercialize two human antibodies from Human Genome Sciences...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Last Issue PDF
RSS